type here...

CATEGORIES

Healthcare

LATEST

1...656667...74Page 66 of 74

TRENDING

EDITORS CHOICE

#HIMSS23 Brings Renewed Energy to the Global Health Information Table

Gil Bashe, Medika Life Editor -
AI, ChatGPT, Health at Home and Interoperability are the Hot Topics at HIMSS23

HPV Urban Legends – From Contagion to Symptoms to Risks to Prevention – There Are More Rare Concerns that Deserve Our Attention

Gil Bashe, Medika Life Editor -
Inaugural International Recurrent Respiratory Papillomatosis Awareness Day

The Era Of Humanology

John Nosta -
A unique combination of human and technological innovations will drive transformation.

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories